Metreleptin (Myalept) – A leptin analog for generalized lipodystrophy

Medical Letter on Drugs and Therapeutics

Volumn 57, Issue 1460, 2015, Pages 13-14

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; LEPTIN; METRELEPTIN;

ABDOMINAL PAIN; ARTICLE; BODY WEIGHT DISORDER; DIABETES MELLITUS; DRUG DOSE TITRATION; HEADACHE; HIV ASSOCIATED LIPODYSTROPHY; HUMAN; HYPERINSULINEMIA; HYPOGLYCEMIA; INSULIN RESISTANCE; LEPTIN DEFICIENCY; LIPODYSTROPHY; METABOLIC DISORDER; NONALCOHOLIC FATTY LIVER; T CELL LYMPHOMA; TRIACYLGLYCEROL BLOOD LEVEL; ANALOGS AND DERIVATIVES; ANIMAL; CHEMISTRY; CLINICAL TRIAL (TOPIC); LIPODYSTROPHY, CONGENITAL GENERALIZED; METABOLISM;

ANIMALS; CLINICAL TRIALS AS TOPIC; HUMANS; LEPTIN; LIPODYSTROPHY, CONGENITAL GENERALIZED;

EID: 84921978149     PISSN: 0025732X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (3)

1. A Garg. Acquired and inherited lipodystrophies. N Engl J Med 2004; 350:1220.
2. MA Tsoukas et al. Leptin in congenital and HIV-associated lipodystrophy. Metabolism 2015; 64:47.
3. Approximate WAC for 30 days' treatment. WAC = wholesaler acquisition cost, or manufacturer's published price to wholesalers; WAC represents published catalogue or list prices and may not represent actual transactional prices. Source: Analy- Source® Monthly. January 5, 2015. Reprinted with permission by First Databank, Inc. All rights reserved. ©2015. www.fdbhealth. com/policies/drug-pricing-policy.